CANSINOBIO
Tianjin CanSino Biotech Inc. is an emerging biotechnology company dedicated to vaccine research, development and commercialization. We seek to address the pressing unmet medical needs by developing and marketing leading-edge, high quality vaccines for China and other emerging markets at affordable prices.
CANSINOBIO
Social Links:
Industry:
Biopharma Biotechnology Health Care Medical Medical Device
Founded:
2009-01-01
Address:
Tianjin, Guangdong, China
Country:
China
Website Url:
http://www.cansinotech.com
Total Employee:
101+
Status:
Active
Contact:
+02225616006
Email Addresses:
[email protected]
Total Funding:
115.97 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible Google Font API Content Delivery Network Google Maps GStatic Google Static Content COVID-19 China Telecom TrustAsia Bootcss
Similar Organizations
Asklepios BioPharmaceutical
Asklepios BioPharmaceutical is a biotechnology company developing adeno-associated virus (AAV) gene therapies for genetic disorders.
AVATAMED
Biotechnology, Biopharmaceutical
Bharat Biotech
India's second biggest vaccines company
Hangzhou Just Biotherapeutics (Just China)
Hangzhou Just Biotherapeutics is a comprehensive high-tech design company.
Pilot Biotechnology
Pilot Biotechnology is an industrial biotechnology company engaged in the development, production, and sales of health care products.
Qihan Biotech
Qihan Biotech is a gene-editing organ transplantation technology developer.
Soligenix
Soligenix is a biopharmaceutical company that develops biodefense vaccines and therapeutics to treat rare diseases.
Current Advisors List
Current Employees Featured
Founder
Stock Details
Investors List
GoldStone
GoldStone investment in Series E - CanSinoBIO
Lilly Asia Ventures
Lilly Asia Ventures investment in Series E - CanSinoBIO
SDIC Fund Management
SDIC Fund Management investment in Series E - CanSinoBIO
Qiming Venture Partners
Qiming Venture Partners investment in Series E - CanSinoBIO
Fortune Capital
Fortune Capital investment in Series E - CanSinoBIO
Gopher Asset Management
Gopher Asset Management investment in Series E - CanSinoBIO
Qiming Venture Partners
Qiming Venture Partners investment in Venture Round - CanSinoBIO
Qiming Venture Partners
Qiming Venture Partners investment in Series C - CanSinoBIO
Lilly Asia Ventures
Lilly Asia Ventures investment in Series C - CanSinoBIO
Lilly Asia Ventures
Lilly Asia Ventures investment in Venture Round - CanSinoBIO
Official Site Inspections
http://www.cansinotech.com Semrush global rank: 2.42 M Semrush visits lastest month: 7.44 K
- Host name: ecs-122-9-81-164.compute.hwclouds-dns.com
- IP address: 122.9.81.164
- Location: Hong Kong
- Latitude: 22.25
- Longitude: 114.1667
- Timezone: Asia/Hong_Kong
